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Osteocytes are the most abundant bone cells, comprising more than 95% of the cells in bone. They are 
embedded into the bone matrix, but extensively communicate among themselves and with cells on the 
bone surface and the bone marrow through the osteocytic lacunar-canalicular network. Osteocytes 
secrete sclerostin, the product of the Sost gene, an antagonist of Wnt signaling that potently inhibits 
bone formation. Osteocytes are also a major source of pro- and anti-osteoclastogenic cytokines that 
regulate osteoclastogenesis and bone resorption, including RANKL and osteoprotegerin (OPG). Recent 
evidence suggests that the bone remodeling compartment is disrupted in multiple myeloma (MM) 
allowing close contact of MM cells with bone cells including osteocytes. However, the consequences of 
these interactions and the contribution of osteocytes to MM bone disease are unclear. Therefore, we 
determined if interactions between MM cells and osteocytes regulate osteocytic gene expression. We 
found that co-culture of murine MLO-A5 osteocytic cells with human JJN3 MM cells up-regulated murine 
Sost mRNA expression 2-3 fold as early as 4h, which remained elevated up to 24h. Consistent with Sost 
up-regulation induced by MM cells, the expression of OPG, a Wnt target gene, was decreased by 30-50% 
in MLO-A5 cells, resulting in an increased RANKL/OPG at 4h. Culture of JJN3 cells in the top and MLO-A5 
cells in the bottom of Boyden chambers abolished both up-regulation of Sost and down-regulation of 
OPG mRNA expression in osteocytic cells, demonstrating the requirement of direct contact between 
MM cells and osteocytic cells. Human Sost and OPG mRNA transcripts were not detected in any of these 
experiments, demonstrating lack of contribution of MM JJN3 cells. These findings demonstrate that 
direct interactions between osteocytes and MM cells up-regulate the expression of the bone formation 
inhibitor Sost in osteocytes, which in turn decreases Wnt signaling, reduces osteocytic OPG expression 
increasing the RANKL/OPG ratio. We propose that increased Sost/Sclerostin expression contributes to 
the exacerbated bone resorption and the decreased bone formation that characterizes MM induced 
bone disease.  
 
